All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)

Total Real Returns

NVO: Total Real Return Chart (Dividends Reinvested, Inflation Adjusted)

NVO real return snapshot: after CPI-U inflation, NVO returned โˆ’30.08% over the past year and โˆ’23.06% YTD, with dividends reinvested. Since Apr. 30, 1981, NVO is up +12,296.45% in real purchasing-power return, or +11.18%/yr, and is currently โˆ’73.36% below its real total-return high on Jun. 25, 2024.

Data ending Fri Oct. 16, 2026

Growth of $10,000

Thu 1981-04-30๐Ÿ’ฌ to Fri 2026-10-16 Overall
Return
Exponential
Trendline
NVO
×
+12,296.45%
+11.18%/yr
+15.37%/yr
R2=0.961
Novo Nordisk A/S NYSE Common Stock

Growth of $10,000 Summary

Thu 1981-04-30๐Ÿ’ฌ to Fri 2026-10-16 Start
Value
End
Value
NVO
×
$10,000.00
1981-04-30
$1,239,645.50
2026-10-16

This Yearโ€™s Performance

through 2026-10-16

  YTD YoY
NVO
×
โˆ’23.06% โˆ’30.08%

Drawdowns

  Current
Drawdown
Worst
Drawdown
NVO
×
โˆ’73.36%
on 2026-10-16
from 2024-06-25 peak
โˆ’75.89%
on 2026-03-27
from 2024-06-25 peak

Rolling Returns

Period ending Fri 2026-10-16 1 yr 2 yr 3 yr 5 yr 10 yr
NVO
×
โˆ’30.08% โˆ’66.82%
โˆ’42.40%/yr
โˆ’61.82%
โˆ’27.45%/yr
โˆ’30.56%
โˆ’7.03%/yr
+77.40%
+5.90%/yr

Annual Returns

Year NVO
2026 (YTD) โˆ’23.06%
2025 โˆ’40.80%
2024 โˆ’18.29%
2023 +49.82%
2022 +15.21%
2021 +52.77%
2020 +21.68%
2019 +25.83%
2018 โˆ’13.76%
2017 +51.03%
2016 โˆ’37.85%
2015 +38.38%
2014 +15.79%
2013 +13.70%
2012 +41.63%
2011 +0.92%
2010 +76.85%
2009 +23.62%
2008 โˆ’19.80%
2007 +51.19%
2006 +47.34%
2005 +1.78%
2004 +30.39%
2003 +41.31%
2002 โˆ’28.92%
2001 +12.46%
2000 +34.19%
1999 โˆ’4.58%
1998 โˆ’8.80%
1997 +52.53%
1996 +33.72%
1995 +41.81%
1994 โˆ’6.06%
1993 +9.24%
1992 โˆ’2.93%
1991 +40.27%
1990 +18.91%
1989 +24.97%
1988 +76.94%
1987 โˆ’37.07%
1986 +11.77%
1985 +20.54%
1984 โˆ’59.00%
1983 +23.58%
1982 +6.12%
1981 +18.17%